
グループ: Randox

カタログの抜粋

Monitoring EQA Performance : Investigating the source of the problem In order to identify the source of the problem it is useful to be aware of the most common causes of poor EQA performance. Errors can occur at any stage of the testing process however EQA is most concerned with detecting analytical errors i.e. errors that occur during the analysis of the sample. Most analytical errors can be easily divided into three main areas; clerical errors, systematic errors and random errors. Systematic errors result in inaccurate results that consistently show a positive or negative bias. Random errors on the other hand affect precision and result in fluctuations in either direction. The flowchart (below) is designed to help you investigate any apparent poor performance. Is the parameter result within acceptable limits of performance? YES • Target Score >50 • SDI <2SDPA • % Deviation < acceptable limits of performance Send corrected result to RIQAS along with relevant documentation to support the case. Verify instrument, method and units are registered correctly for each parameter. Especially important for initial submission and when registration changes have been made. Review the summary page. Are the majority of results flagged? Advise RIQAS of correct details Review Levey-Jennings charts. Are any points outside +/- 1SD? Review instrument parameters and calibration. Has the reagent batch been changed? Review IQC results from the time the EQA sample was tested. Look for trends within the data • Positive/Negative bias • Poor precision • Changes in performance due to change in reagent, calibrator or standardisation There may be a problem specific to that sample • Incorrect sample tested • Reconstitution error • Sample storage Look for shifts or trends Investigate and take corrective action The largest global EQA scheme QUALITY CONTROL Information correct at time of print. Randox Laboratories Ltd is a subsidiary of Randox Holdings Limited a company registered within Northern Ireland with company number N.I. 614690. VAT Registered Number: GB 151 6827 08. Product availability may vary from country to country. Please contact your local Randox representative for information. Products may be for Research Use Only and not for use in diagnostic procedures in the USA. Review performance over the cycle Verify that the reported result and units reflect what was obtained. Has a transcription
カタログの1ページ目を開くRandox Laboratories/ランドックスのすべてのカタログと技術パンフレット
-
LT735 Vivalytic Overview
32 ページ
-
Acusera New Controls
8 ページ
-
Acusera 24.7
24 ページ
-
Acusera Third Party Controls
108 ページ
-
Acusera SMART Controls
12 ページ
-
Company Overview
40 ページ
-
Reagents Brochure
64 ページ
-
sdLDL-C
8 ページ
-
RX modena
20 ページ
-
RX misano
20 ページ
-
RX Daytona Plus
20 ページ
-
Rx Imola
20 ページ
-
RX Monaco
20 ページ
-
2024 Product List
64 ページ
-
VeraSTAT-V
16 ページ
-
LT033 RIQAS Explained
64 ページ
-
VERASTAT
16 ページ
-
Endocrine Array
4 ページ
-
Cerebral Arrays
4 ページ
-
Thyroid Arrays
4 ページ
-
Basic QC Stastics
8 ページ
-
Commutability Guide
4 ページ
-
Qnostics
52 ページ
-
Adiponectin LT519
28 ページ
-
Specific Proteins
40 ページ
-
Linearity sets
12 ページ
-
Antioxidants
16 ページ
-
Diabetes Portfolio
28 ページ
-
Total Bile Acids
4 ページ
-
VIVALYTIC
30 ページ
-
RANDOX DISCOVERY
36 ページ
-
HbA1c
2 ページ
-
Preparing QC
1 ページ
-
Point of Care Testing
12 ページ
-
Guide to running QC
1 ページ
-
Tumour Marker Arrays
4 ページ
-
LT169 Cardiac Array
4 ページ
カタログアーカイブ
-
ACUSERA
108 ページ
-
Evidence Evolution
28 ページ
-
Evidence
16 ページ
-
STI Multiplex Array
8 ページ
-
Molecular Testing
16 ページ
-
Evidence Investigator
20 ページ
-
Fertility Array
4 ページ
-
Rx Daytona
16 ページ
-
Evidence Investigator
16 ページ
-
Evidence
16 ページ